270 related articles for article (PubMed ID: 29593032)
1. Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.
Becker M; Greune L; Schmidt MA; Schelhaas M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593032
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.
Cerqueira C; Samperio Ventayol P; Vogeley C; Schelhaas M
J Virol; 2015 Jul; 89(14):7038-52. PubMed ID: 25926655
[TBL] [Abstract][Full Text] [Related]
3. Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions.
Schäfer G; Graham LM; Lang DM; Blumenthal MJ; Bergant Marušič M; Katz AA
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566373
[TBL] [Abstract][Full Text] [Related]
4. Epidermal Growth Factor Receptor and Abl2 Kinase Regulate Distinct Steps of Human Papillomavirus 16 Endocytosis.
Bannach C; Brinkert P; Kühling L; Greune L; Schmidt MA; Schelhaas M
J Virol; 2020 May; 94(11):. PubMed ID: 32188731
[TBL] [Abstract][Full Text] [Related]
5. Target cell cyclophilins facilitate human papillomavirus type 16 infection.
Bienkowska-Haba M; Patel HD; Sapp M
PLoS Pathog; 2009 Jul; 5(7):e1000524. PubMed ID: 19629175
[TBL] [Abstract][Full Text] [Related]
6. The evolving field of human papillomavirus receptor research: a review of binding and entry.
Raff AB; Woodham AW; Raff LM; Skeate JG; Yan L; Da Silva DM; Schelhaas M; Kast WM
J Virol; 2013 Jun; 87(11):6062-72. PubMed ID: 23536685
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry.
Bienkowska-Haba M; Williams C; Kim SM; Garcea RL; Sapp M
J Virol; 2012 Sep; 86(18):9875-87. PubMed ID: 22761365
[TBL] [Abstract][Full Text] [Related]
8. Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.
Bronnimann MP; Calton CM; Chiquette SF; Li S; Lu M; Chapman JA; Bratton KN; Schlegel AM; Campos SK
J Virol; 2016 Jul; 90(14):6224-6234. PubMed ID: 27122588
[TBL] [Abstract][Full Text] [Related]
9. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection.
Cruz L; Biryukov J; Conway MJ; Meyers C
Viruses; 2015 Nov; 7(11):5813-30. PubMed ID: 26569287
[TBL] [Abstract][Full Text] [Related]
11. Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.
DiGiuseppe S; Keiffer TR; Bienkowska-Haba M; Luszczek W; Guion LG; Müller M; Sapp M
J Virol; 2015 Oct; 89(20):10442-52. PubMed ID: 26246568
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of cell entry by human papillomaviruses: an overview.
Horvath CA; Boulet GA; Renoux VM; Delvenne PO; Bogers JP
Virol J; 2010 Jan; 7():11. PubMed ID: 20089191
[TBL] [Abstract][Full Text] [Related]
13. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
Wiens ME; Smith JG
J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
[TBL] [Abstract][Full Text] [Related]
14. Exogenous Vimentin Supplementation Transiently Affects Early Steps during HPV16 Pseudovirus Infection.
Carse S; Lang D; Katz AA; Schäfer G
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960740
[TBL] [Abstract][Full Text] [Related]
15. The papillomavirus major capsid protein L1.
Buck CB; Day PM; Trus BL
Virology; 2013 Oct; 445(1-2):169-74. PubMed ID: 23800545
[TBL] [Abstract][Full Text] [Related]
16. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
[TBL] [Abstract][Full Text] [Related]
17. Further evidence that papillomavirus capsids exist in two distinct conformations.
Selinka HC; Giroglou T; Nowak T; Christensen ND; Sapp M
J Virol; 2003 Dec; 77(24):12961-7. PubMed ID: 14645552
[TBL] [Abstract][Full Text] [Related]
18. Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs).
Spoden G; Freitag K; Husmann M; Boller K; Sapp M; Lambert C; Florin L
PLoS One; 2008 Oct; 3(10):e3313. PubMed ID: 18836553
[TBL] [Abstract][Full Text] [Related]
19. Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16.
Richards KF; Bienkowska-Haba M; Dasgupta J; Chen XS; Sapp M
J Virol; 2013 Nov; 87(21):11426-37. PubMed ID: 23966387
[TBL] [Abstract][Full Text] [Related]
20. The endocytic trafficking pathway of oncogenic papillomaviruses.
Mikuličić S; Florin L
Papillomavirus Res; 2019 Jun; 7():135-137. PubMed ID: 30946955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
